GuidoDalbagniMD

Professor, Urology, Weill Cornell Medical College

Overview of Dr. Dalbagni

Dr. Guido Dalbagni is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Cairo University School of Medicine and has been in practice 37 years. Dr. Dalbagni accepts several types of health insurance, listed below. He is one of 73 doctors at Memorial Sloan Kettering Cancer Center and one of 2 doctors at Memorial Sloan Kettering Bergen who specialize in Urology. He has more than 100 publications and over 500 citings.

Office
353 East 68th Street
New York, NY 10065
Book by Phone+1(631) 458-1773

Education & Training

NYU Grossman School of MedicineResidency, Urology, 1984 - 1988
Icahn School of Medicine at Mount Sinai (Cabrini)Residency, Surgery, 1982 - 1984
Cairo University School of MedicineClass of 1980

Certifications & Licensure

NY State Medical License 1989 - 2026
NJ State Medical License 1986 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Quality of Life in Patients With Bladder Cancer Start of enrollment: 2008 Aug 01
Active, not recruiting
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer Start of enrollment: 2009 Jun 01
Terminated
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Start of enrollment: 2009 Sep 01
Terminated
Phase 3
RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder Start of enrollment: 2010 Dec 01
Completed
Phase 1, Phase 2
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment Start of enrollment: 2019 Nov 22
Recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

32 citations
Preoperative Accuracy of Diagnostic Evaluation of the Urachal Mass
Joshua J. Meeks, Harry W. Herr, Melanie Bernstein, Hikmat Al-Ahmadie, Guido Dalbagni
The Journal of Urology. 2012-04-01
90 citations
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky, Bernard H. Bochner, Guido Dalbagni
Journal of Clinical Oncology. 2018-05-09
125 citations
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
Bernard H Bochner, Guido Dalbagni, Daniel D Sjoberg, Jonathan Silberstein, Gal E Keren Paz
European Urology. 2015-06-01

Professional Memberships

American College of Surgeons - ACS
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Aetna Whole Health Banner Health Network
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment